Literature DB >> 23061777

Challenges of drug risk communications in the Philippines.

Kenneth Hartigan-Go1.   

Abstract

Risk communication in the context of patient care is about conveying balanced information on benefit and risk of medical products and procedures and developments in health. It is an integral part of pharmacovigilance and healthcare communications and involves stakeholders such as regulators, industry, health professionals and patients. In the Philippines, many factors can interfere with effective risk communication and affect the safety of patients when medicinal products are used: poverty, literacy, age, social media, practice and behaviour of health professionals, industry marketing, patient expectations and product quality. These factors must be taken into consideration when formulating effective risk communications to ensure patient safety.

Entities:  

Mesh:

Year:  2012        PMID: 23061777     DOI: 10.1007/bf03261987

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  11 in total

Review 1.  Toxic heavy metals and undeclared drugs in Asian herbal medicines.

Authors:  Edzard Ernst
Journal:  Trends Pharmacol Sci       Date:  2002-03       Impact factor: 14.819

Review 2.  Risk management from an Asian/Pacific Rim regulatory perspective.

Authors:  John McEwen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  The India HPV-vaccine suspension.

Authors:  Heidi J Larson; Pauline Brocard; Geoffrey Garnett
Journal:  Lancet       Date:  2010-08-21       Impact factor: 79.321

4.  The costs of prescribing in dispensing practices.

Authors:  D L Baines; K H Tolley; D K Whynes
Journal:  J Clin Pharm Ther       Date:  1996-10       Impact factor: 2.512

5.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly.

Authors:  N Col; J E Fanale; P Kronholm
Journal:  Arch Intern Med       Date:  1990-04

6.  Consultation length in general practice: cross sectional study in six European countries.

Authors:  Myriam Deveugele; Anselm Derese; Atie van den Brink-Muinen; Jozien Bensing; Jan De Maeseneer
Journal:  BMJ       Date:  2002-08-31

7.  Prescription habits of dispensing and non-dispensing doctors in Zimbabwe.

Authors:  Birna Trap; Ebba Holme Hansen; Hans V Hogerzeil
Journal:  Health Policy Plan       Date:  2002-09       Impact factor: 3.344

8.  A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report.

Authors:  Gilbert Lau; Danny S T Lo; Y J Yao; H T Leong; Cheng Leng Chan; Swee Seng Chu
Journal:  Med Sci Law       Date:  2004-07       Impact factor: 1.266

9.  Truth or fallacy? Three hour wait for three minutes with the doctor: Findings from a private clinic in rural Japan.

Authors:  Adam N Wooldridge; Nóra Arató; Ananda Sen; Masaki Amenomori; Michael D Fetters
Journal:  Asia Pac Fam Med       Date:  2010-11-23

10.  Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management.

Authors:  Richard D Smith
Journal:  Soc Sci Med       Date:  2006-09-15       Impact factor: 4.634

View more
  5 in total

1.  The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Authors:  Priya Bahri; Alexander N Dodoo; Brian D Edwards; I Ralph Edwards; Irene Fermont; Ulrich Hagemann; Kenneth Hartigan-Go; Bruce Hugman; Peter G Mol
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.606

2.  Empowering consumers as contributors for health product safety: lessons from the Philippines.

Authors:  Kenneth Hartigan-Go
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

3.  Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia.

Authors:  Rema Panickar; Zoriah Aziz; Adeeba Kamarulzaman
Journal:  BMC Public Health       Date:  2022-07-05       Impact factor: 4.135

4.  Evaluation of pharmaceutical pictogram comprehension among adults in the Philippines.

Authors:  Margarita M Gutierrez; Chanthawat Patikorn; Puree Anantachoti
Journal:  J Pharm Policy Pract       Date:  2022-04-07

5.  Focusing on risk communication about medicines: why now?

Authors:  Priya Bahri; Mira Harrison-Woolrych
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.